Work

Successful Therapy of a Patient with a Novel STAT1 Gain of Function Mutation and Life-Threatening Cytopenias with Janus Kinase Inhibitor Ruxolitinib

Year: 2015

Type: article

Study design: Case Report

Source: Blood

DOI: 10.1182/blood.v126.23.3434.3434

Authors: Katja G. Weinacht, Louis m Charbonnier, Ashley Plant, Troy Torgerson, Sergei Rosenzweig, Thomas Fleisher, Luigi Daniele Notarangelo

Institutions: Boston Children's Hospital, Dana-Farber Cancer Institute, University of Washington, Seattle Children's Research Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2548364987

FWCI: 0.164

Cites:

Cited by: 2

Related to: 10